Introduction
Lipopolysaccharide (LPS, endotoxin) is a cell wall component of Gram negative bacteria. LPS activates immune cells and triggers production of proinflammatory cytokines and other mediators, which upregulate host immune defense systems and eliminate the bacterial infection 1 . LPS hyporesponsive mice are susceptible to Gram negative bacteria infection 2 . On the other hand, excessive or prolonged production of LPS-induced mediators can result in septic shock, a life-threatening condition 1 .
However, a process, endotoxin tolerance, in which exposure to LPS renders immune cells tolerant to subsequent LPS stimulation, helps to keep responses to LPS under control 1, 3 . Endotoxin-tolerant macrophages, for instance, produce lower levels of the proinflammatory cytokines, TNF-and IL-6, both of which play important roles in septic shock 3 . Little was known about the mechanism by which LPS interacts with immune cells until the Toll-like receptor (TLR) family were identified in mammalian cells 4, 5 . TLRs recognize conserved microbial components and function as critical sentinel receptors to initiate immune responses against microbial infections. TLR2, TLR4 and TLR9 recognize LTA (lipoteichoic acid), LPS and CpG motif of bacterial DNA, respectively. Given the important physiological and pathological relevance of LPS response, the mechanism of LPS-induced TLR4 signaling has been intensively studied, but remains incompletely defined 4, 5 . Through recruitment of adaptor proteins such as MyD88 and TRIF, TLR4 activates downstream mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 1/2 (ERK1/2), p38
and c-Jun NH2-terminal kinase (JNK), and NF-B. Activation of MAPKs and NF-B
For personal use only. on . by guest www.bloodjournal.org From represent the last events of cytoplasmic TLR4 signal transduction and are essential for LPS-induced production of proinflammatory cytokines 4, 5 . IRAK-M and SOCS1
function as negative regulators of TLR signal transduction and are considered as key molecules in the development of endotoxin tolerance [4] [5] [6] [7] . As such, these signaling molecules are targets for the modulation of LPS response. Identifying positive and negative regulators and the pathways of LPS signaling will provide insights into the mechanism of TLR signal transduction, rendering us the ability to finely orchestrate LPS-and other TLR agonist-induced responses, so as to eliminate microbial infection while protecting against lethal host responses.
Src homology (SH) 2 domain-containing inositol-5-phosphatase 1 (SHIP1) was initially identified as a 145-kD protein that negatively regulated BCR signaling by catalyzing the Phosphoinositide 3-kinase (PI-3K) product PtdIns-3,4,5P3 into PtdIns-3,4P2 8, 9 . SHIP1 also inhibits PI-3K activation induced by IgE and cytokines 10 .
In addition, SHIP1 can inhibit activation of ERK1/2, JNK and NF-B pathways [11] [12] [13] .
All of these pathways play important roles in LPS signaling 4, 5, 14, 15 . However little is known about the role of SHIP1, as an important immune inhibitory molecule, in LPS-induced inflammatory response.
We have investigated whether SHIP1 participates in LPS signaling in TLR4-reconstituted COS7 cells and macrophage cell line RAW264.7. Unexpectedly, in addition to phosphatase activity-dependently inhibiting LPS-induced PI-3K
activation, SHIP1 also phosphatase activity-and PI-3K-indepedently inhibits LPS-induced activation of MAPKs and the production of TNF-. Our present study
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For personal use only. on . by guest www.bloodjournal.org From
Materials and methods

Reagents
LPS (0111:B4) was purchased from Sigma (St. Louis, MO) and re-purified as described previously 16 . Antibodies specific to SHIP1, ERK1/2, p38, JNK, TLR4, MyD88, phospho-ERK1/2, phospho-tyrosine and horseradish peroxidase-coupled secondary antibodies were obtained from Santa Cruz (Santa Cruz, CA). Antibodies specific to phospho-JNK and phospho-p38 were purchased from Promega (Madison, WI). LY294002, LY303511, Wortmannin, and protease inhibitor cocktail were from Calbiochem (San Diego, CA).
Plasmid constructs
The expression vector pBK-CMV/150.8SHIP1 (SHIP1) was a kind gift from Dr. 
Culture and transfection of RAW264.7 macrophages and COS7 cells
The murine macrophage cell line RAW 264.7 and monkey kidney cell line COS7
were obtained from the American Type Culture Collection (Manassas, VA) and cultured as described previously 21 . For Western blotting, 2x10 6 cells, seeded into 60mm dishes one day prior to transfection, were transfected with 5µg DNA using Superfect Reagent (Qiagen, Hilden, Germany). For ELISA assays, 2x10 5 cells were seeded into 24-well plates and incubated overnight before LPS stimulation. In some SHIP1 knockdown experiments, the cells were cotransfected with a GFP-expressing plasmid pGFP, and GFP-expressing cells were sorted with a FACSDiVa system (Becton Dickinson) 22 . SHIP1 stably transfected cells were selected with 300µg/ml G418 (Invitrogen, Carlsbad, CA).
Detection of IL-6 and TNF-
RAW264.7 macrophages were stimulated with 100ng/ml LPS for indicated time periods. The concentrations of IL-6 and TNF-in culture supernatants were measured using mouse IL-6 and mouse TNF-ELISA Kits (R&D Systems, Minneapolis, MN), according to manufacturer's instructions. 
Ras activation assay
Ras activation was detected using Ras Activation Assay Kit (Upstate Biotechnology, Inc.) according to manufacturer's instructions. In brief, RAW264. 
Densitometrical analysis
Densitometrical analysis was done with Labworks Image Acquisition and Analysis Software (UVP Inc., Upland, CA). The background was subtracted, and the signals of the detected bands were normalized to the amount of loading control band.
The relative values were presented as fold increase over control samples as indicated.
Statistical Analysis
Statistical significance was determined by Student's t test, with a value of P<0.01 considered to be statistically significant. 
Results
SHIP1 participates in LPS signaling and inhibits LPS-induced cytokine production in macrophages
To study whether SHIP1 was involved in LPS signal transduction, we detected the phosphorylation of endogenous SHIP1 in RAW264.7 macrophages following LPS stimulation. As shown in Fig.1A , LPS stimulation prompted an increase in tyrosine phosphorylation of SHIP1, and the phosphorylation of SHIP1 was enhanced over time, suggesting SHIP1 might play a role in LPS signaling. In addition, the expression of SHIP1 was also upregulated, which increased at 4h and peaked at 8-12h after LPS stimulation ( pU6-SHIP1 or control plasmid pU6 transfected cells were stimulated with LPS, and production of TNF-and IL-6 in the cells were detected. SHIP1 knockdown cells produced 1.7-fold TNF-and 1.9-fold IL-6 of that produced by mock-transfected cells (P<0.01 for U6 vs U6-SHIP1) upon LPS stimulation (Fig.1D ), demonstrating that SHIP1 could inhibit LPS-induced inflammatory response in macrophages. Our experiments demonstrate that this is also the case for LPS-induced ERK1/2 and JNK1/2 activation, which was strongly inhibited by the PI-3K specific inhibitor LY294002 (Fig.3A) . In contrast, LPS-induced p38 phosphorylation was enhanced by LY294002 treatment (Fig.3A) , which was consistent with the previously reported inhibitory role of PI-3K in LPS-induced p38 activation in DCs 15 .
SHIP1 negatively regulates LPS-induced activation of PI-3K pathway in
We next investigated whether SHIP1 regulated LPS-induced activation of MAPKs through PI-3K pathway. Unlike LY294002 treatment, SHIP1 overexpression not only inhibited LPS-induced ERK1/2 and JNK activation, but also inhibited LPS-induced p38 MAPK activation (Fig3.B). The contrary effects of SHIP1 overexpression and LY294002 treatment on LPS-induced p38 activation suggested that SHIP1 might regulate LPS-induced p38 activation primarily via an alternative PI-3K-independent pathway. Consistently, phosphatase-inactive mutant SHIP1 could also inhibited LPS-induced ERK1/2, p38, JNK activation, suggesting that SHIP1 regulate LPS-induced activation of MAPKs primarily via phosphatase activity-and PI-3K-independent pathway. To confirm the conclusion, PI-3K inhibitor LY294002
and Wortmannin were used to inhibit PI-3K activation. As shown in Fig.3C and 3D, neither of them could efficiently diminish wild-type and mutant SHIP1 mediated inhibition of LPS-induced ERK1/2, p38, JNK activation.
We further observed the effect of SHIP1 knockdown on LPS-induced activation of ERK1/2, p38 and JNK. Consistent with the above results, LPS-induced phosphorylation of ERK1/2, p38 and JNK was significantly enhanced in SHIP1 knockdown cells compared with that in control cells, in spite of the absence or For personal use only. on . by guest www.bloodjournal.org From presence of LY294002 ( Fig.3E and 3F ), demonstrating that SHIP1 regulates LPS-induced activation of MAPKs primarily by PI-3K-independent mechanism in macrophages.
SHIP1 inhibits LPS-induced I B-degradation but enhances NF-B activation in macrophages
NF-B pathway plays an important role in TLR4 signal transduction. We investigated the role of SHIP1 in NF-B activation by detecting NF-B luciferase reporter gene expression. Unexpectedly, SHIP1 knockdown dose-dependently inhibited LPS-induced NF-B activation (Fig.4A) . Consistently, SHIP1 overexpression dose-dependently enhanced LPS-induced NF-B activation (Fig.4B) .
We also detected LPS-induced NF-B luciferase activity in SHIP1 or control vector stably transfected RAW264.7 macrophages. SHIP1 stable overexpression also increased LPS-induced NF-B luciferase activity (data not shown). We further observed the effect of SHIP1 knockdown on LPS-induced I B-degradation. While SHIP1 knockdown enhanced LPS-induced I B-degradation (Fig.4C) , SHIP1 overexpression inhibited LPS-induced I B-degradation (Fig.4D) . These results suggest that SHIP1 positively regulates LPS-induced NF-B activation through an I B--independent mechanism.
SHIP1 inhibits LPS-induced TNFproduction by both phosphatase activity-dependent and -independent mechanisms in macrophages
To confirm the roles of SHIP1's phosphatase activity and PI-3K pathway in We also observed whether PI-3K inhibitor, LY294002 or Wortmannin, could affect SHIP1-mediated inhibition of LPS-induced TNF-production. SHIP1 or mock-transfected RAW264.7 macrophages were stimulated with LPS in the presence of DMSOዊLY303511, LY294002 or Wortmanninዊand TNF-production in the supernatants was quantified (Fig.5B) . Consistent with previous studies, LY294002 could partially inhibit LPS-induced TNF-production, but Wortmannin did not inhibit TNF-production 14 . However, neither of them could significantly diminish SHIP-mediated inhibition of TNF-production. PI-3K activity assay showed that LY294002 and Wortmannin used in the experiments were effective in blocking PI-3K activation (Fig.5C ). These results suggest that PI-3K-independent pathway functions in SHIP1-mediated inhibition of LPS-induced inflammatory response.
SHIP1-mediated inhibition of LPS-induced inflammatory response, we compared the
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SHIP1 inhibits LPS-induced Ras activation and TLR4-MyD88 complex formation
Ras is an important signal intermediator in the activation of immune cells, and 
SHIP1 inhibits LPS-induced MAPKs activation in TLR4-reconstituted COS7 cells
As re-purified LPS activates macrophages exclusively through TLR4 25 
Discussion
In this study, we demonstrated that SHIP1 was phosphorylated and then and MyD88 translocate into lipid rafts 28, 29 . SHIP1 also translocates into lipid rafts following LPS treatment 30 . It is intriguing to suspect whether SHIP1 could inhibit the translocation of TLR4 and MyD88 into lipid raft or whether SHIP1 could inhibit the combination between TLR4 and MyD88 in lipid raft by a competitive mechanism. We sought to identify the association between endogenous SHIP1 and the intermediates involved in TLR4 signal transduction following LPS stimulation. However, we failed to detect the known intermediates including MyD88, IRAK1 and TRAF6 in immuno-coprecipitation experiments using SHIP1 specific antibody (data not shown).
Translocation to membrane was reported to be essential for the regulatory activity of SHIP1 31, 32 . In this case, identification of specific and direct interactions between SHIP1 and the intermediates might be difficult 32 .
In TLR4 signal transduction, PI-3K is activated downstream MyD88 In conclusion, we provided the first evidence that SHIP1 can inhibit LPS-induced inflammatory response through phosphatase activity-and PI-3K-independent mechanism. In addition to inhibiting LPS-induced PI-3K activation, SHIP1 inhibits LPS-induced TLR4-MyD88 combination and Ras activation, and subsequently inhibits LPS-induced activation of MAPKs, that is primarily in phosphatase activity-and PI-3K-independent manner. These results suggest RNA interfering and ectopic expression targeting SHIP1 might provide novel therapeutic strategies to modulate LPS response.
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